Navigation Links
NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
Date:10/13/2008

ab) versus Lucentis alone.

About NeoVista, Inc.

NeoVista, Inc. is a privately held development-stage medical device company based in Fremont, California. NeoVista's epiretinal beta radiation therapy is currently being studied in a definitive Phase III clinical study to support eventual filing for regulatory approval to market the product in the United States. For more information about the company, the clinical trial or this novel wet AMD therapy, please visit the company's Web site at http://www.neovistainc.com .


'/>"/>
SOURCE NeoVista, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer
2. The Lewin Group Presents McCain and Obama Health Policies: Cost and Coverage Compared Analysis
3. Stater Bros. Markets Presents $1,143,000 Check to Muscular Dystrophy Association
4. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
5. AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska
6. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
7. AMA Foundation Presents $10,000 Scholarships to Promising Medical Students
8. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
9. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
10. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
11. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 3Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 2Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 3Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 2Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 3Health News:States Slash Funding for Tobacco Prevention Programs 2Health News:States Slash Funding for Tobacco Prevention Programs 3
Breaking Medicine Technology:Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Confusion Over Homeopathic Medicines in Alexa Ray Joel's Hospitalization Clarified by the American Association of Homeopathic Pharmacists (AAHP) 2Al Novak Elected Chairman of the Board of OrbusNeich Medical 2CMPI to Host Hill Briefing Tomorrow on Follow on Biologic Drugs for Media and Congressional Staff With Reps Eshoo and Rogers 51694 1CMPI to Host Hill Briefing Tomorrow on Follow on Biologic Drugs for Media and Congressional Staff With Reps Eshoo and Rogers 51694 2Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 1Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 2Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 3Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 4Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences 28R 29 to Provide World Class Fluid Management and Liquid Powder 51692 5Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 1Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 2Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 3